Co-Occurring Disorders Editor · Last reviewed January 2025
The co-occurrence of borderline personality disorder (BPD) and substance use disorders is one of the most clinically significant presentations in behavioral health treatment. Understanding how these two conditions interact, which came first, and how integrated treatment addresses both simultaneously is essential for effective care.
Prevalence and the Bidirectional Relationship
Lifetime co-occurrence of BPD and substance use disorders is estimated at 50–70% — among the highest comorbidity rates in psychiatric epidemiology. The primary mechanism is BPD's impulsivity dimension, which increases risk for substance initiation and escalation. Emotional dysregulation — the cardinal feature of BPD — drives substance use as emotional regulation: substances provide temporary relief from the intense, rapidly shifting emotional states of BPD. Alcohol, stimulants, and cannabis are the most commonly co-occurring substances. The relationship is bidirectional and mutually reinforcing: mental health symptoms drive substance use as self-medication, and substance use worsens, triggers, or maintains mental health symptoms through direct neurobiological effects and disruption of sleep, social functioning, and daily routines.
Diagnostic Complexity
Accurately diagnosing both conditions in the context of active substance use is challenging. Many substances produce psychiatric symptoms during intoxication or withdrawal that mimic primary mental health conditions. Comprehensive dual diagnosis assessment by a clinician trained in both areas — ideally after a period of sobriety or stable use — is essential. That said, severe psychiatric symptoms may require immediate treatment regardless of substance use status.
Why Sequential Treatment Often Fails
When mental health symptoms are driving substance use as self-medication, leaving those symptoms untreated undermines sobriety. When substance use is maintaining psychiatric symptoms through neurobiological dysregulation or psychological avoidance, leaving addiction untreated undermines psychiatric treatment. Integrated simultaneous treatment consistently outperforms sequential approaches in the research literature.
Integrated Treatment
DBT-SUD — Dialectical Behavior Therapy adapted for BPD with substance use disorders — has the strongest evidence base for this co-occurring presentation. Multiple RCTs support DBT-SUD over treatment-as-usual, demonstrating reductions in drug use, suicide attempts, and psychiatric hospitalizations. Key DBT-SUD adaptations include dialectical abstinence (absolute commitment combined with radical acceptance of relapse, preventing the shame-driven abstinence violation effect), clear mind (the state of abstinent vigilance), and burning bridges (eliminating substance access while building a life worth living). Pharmacotherapy for BPD is symptom-targeted — SSRIs for mood lability and depression, low-dose antipsychotics for transient psychotic or dissociative symptoms, mood stabilizers for severe affective instability.
Finding Integrated Treatment
SAMHSA's National Helpline (1-800-662-4357) and treatment locator at findtreatment.gov identify programs with dual diagnosis specialty. When evaluating programs, ask specifically whether both conditions are treated simultaneously, whether a psychiatric prescriber is on staff, and what evidence-based co-occurring disorders treatments are used.
Related: DBT for Co-Occurring Disorders · BPD Overview · Trauma-Informed Care